​

Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

OverviewForecastFinancialsChart

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 25.42% institutional investors, 1.29% insiders, and 73.29% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 6.73% of CGTX shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.73% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCognition Therapeutics25.42%1.29%73.29%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M6.73%$6.90M
Davenport4.26M4.78%$4.90M
Vanguard group3.32M4.26%$4.48M
Vanguard capital management3.44M3.86%$3.95M
Tang capital management1.20M1.88%$1.62M
Blackrock funding, inc. /de1.26M1.41%$1.45M
Chescapmanager997.03K1.12%$1.15M
Geode capital management910.01K1.02%$1.05M
Renaissance693.29K0.78%$797.28K
Hilton capital management548.95K0.62%$631.29K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M16.56%$6.90M
Dauntless investment group371.70K0.34%$427.46K
Cm management450.00K0.33%$517.50K
Chescapmanager997.03K0.10%$1.15M
American financial group205.00K0.08%$235.75K
Tang capital management1.20M0.06%$1.62M
Hilton capital management548.95K0.04%$631.29K
Davenport4.26M0.02%$4.90M
Fca corp /tx52.54K0.01%$60.42K
Sigma planning362.26K0.01%$416.61K

Top Buyers

HolderShares% AssetsChange
Davenport4.26M0.02%1.37M
Tang capital management1.20M0.06%1.20M
Vanguard group3.32M0.00%635.91K
Vanguard capital management3.44M0.00%436.99K
Blackrock funding, inc. /de1.26M-293.63K

Top Sellers

HolderShares% AssetsChange
Acadian asset management---701.94K
Awm investment company---650.00K
Renaissance693.29K0.00%-423.85K
Jane street group---370.14K
Timelo investment management---361.40K

New Positions

HolderShares% AssetsChangeValue
Tang capital management1.20M0.06%1.20M$1.62M
Sixth street partners management company84.94K-84.94K$97.68K
Envestnet asset management30.00K-30.00K$49.80K
Citigroup7.62K-7.62K$8.76K
Global retirement partners2.00K-2.00K$2.30K

Sold Out

HolderChange
Caitong asset management-1.00
Jpmorgan chase-69.00
Mai capital management-250.00
Opal wealth advisors-500.00
Nova wealth management-500.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202667-10.67%22,675,1365.87%254.41%28-9.68%10-23.08%
Mar 31, 202638-51.28%15,601,171-27.18%212.84%16-51.52%5-68.75%
Dec 31, 202551-26.09%19,284,989-9.33%242.22%19-64.81%980.00%
Sep 30, 20256433.33%21,298,05889.46%3310.73%49172.22%4-42.86%
Jun 30, 202548-11,241,507-3.32%174.99%18-10.00%7-36.36%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor2.44M2.73%237.50K
Vanguard Total Stock Mkt Idx Inv2.44M2.73%237.50K
Vanguard MStar Total Stk Mkt Idx Invest2.44M2.57%-
Vanguard Institutional Extnd Mkt Idx Tr923.90K0.97%-
Fidelity Extended Market Index419.67K0.47%3.53K
iShares Micro-Cap ETF271.61K0.30%-3.62K
Extended Equity Market Fund E156.05K0.17%-
Extended Equity Market Fund B156.05K0.17%-
Blackrock Extended Mkt Fund CF156.05K0.17%-
BlackRock Extended Equity Market K64.70K0.16%-27.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 16, 2026Doyle John Brendan Chief Financial OfficerBuy$11.30K
Apr 16, 2026Ricciardi Lisa CEO & PresidentBuy$10.09K
Apr 16, 2026Caggiano Anthony Chief Medical OfficerBuy$11.10K
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q11-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 25.42%, followed by 1.29% insiders and 73.29% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 379.61%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 6.73%), Davenport (4.26M shares, 4.78%), and Vanguard group (3.32M shares, 4.26%). Together, they hold 15.76% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cognition Therapeutics.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.56% of its assets in 6M Cognition Therapeutics shares, valued at 6.9M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Cognition Therapeutics shares, with 2.73% of its total shares outstanding invested in 2.44M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools